Gut Bacteria May Be One Culprit for Increase of Colorectal Cancer in Younger People
January 21st, 2020
Fax: (202) 444-1229
John Marshall, MD
Director, Ruesch Center;
Division Chief, Hematology-Oncology, MedStar/Georgetown Hospital;
Associate Director for Clinical Research, Georgetown Lombardi
You will be redirected to our clinical partner, MedStar Georgetown University Hospital.
Gastrointestinal (GI) cancers remain among the most fatal cancers. Advances in treatment have lagged well behind other disease priorities such as breast cancer because of a smaller pool of research funding and fewer survivors to carry the torch of advocacy.
The Otto J. Ruesch Center for the Cure of Gastrointestinal Cancers at Georgetown Lombardi Comprehensive Cancer Center and MedStar Georgetown University Hospital focuses on national efforts on curing this deadly set of diseases. Combining expertise in molecular medicine, translational research, and a patient-centered philosophy, the Ruesch Center realizes the dream of individualized curative therapies through research, care, and advocacy.
From the National Cancer Institute at the National Institutes of Health, find current information and resources on gastrointestinal cancers, incidence and survival statistics, treatment options, causes and prevention, coping strategies, clinical trials and research.
Gastrointestinal cancers include: Anal Cancer, Colorectal (Colon) Cancer, Esophageal Cancer, Gallbladder Cancer, Gastrointestinal Carcinoid Tumors, Liver Cancer, Pancreatic Cancer, Small Intestine Cancer, Stomach (Gastric) Cancer.
Dramatic improvements in molecular biology have led to a better understanding of what makes cancers “tick.” New anti-cancer agents are being developed at an unprecedented pace. New technologies allow us to measure the many variables quickly and accurately. Improvements in bioinformatics allow us to analyze the resulting data sets. These advances form the foundation of personalized medicine, the only way forward in the quest to cure cancer.
Georgetown Lombardi’s world-renowned research faculty are discovering cancer risk factors, designing effective prevention strategies, and learning how to detect cancers earlier. They are developing and testing the cancer treatments of tomorrow — targeted therapies that will improve both survival and quality of life. They are making progress toward the ultimate goal: to eradicate cancer.
Scientific Presentations at 2019 Ruesch Symposium Inspire
December 9th, 2019
Katie Couric is the Inaugural Speaker at Georgetown's Edward M. Kovach Cura Personalis Endowed Lecture
August 10th, 2019
On Aug. 7, Georgetown Lombardi welcomed Katie Couric, an award-winning journalist and the co-founder of cancer advocacy nonprofit Stand Up To Cancer, for the inaugural Edward M. Kovach Cura Personalis Endowed Lecture.
Ruesch Center Offers Summer Interns an In-Depth Look at GI Oncology
July 9th, 2019
The summer internship program at Georgetown’s Ruesch Center for the Cure of Gastrointestinal Cancers provides 12 students from schools across the country the opportunity to learn about all aspects of GI oncology.